Biologics

Orthopedic fixation company, Ossio, won the 2019 Frost & Sullivan North America New Product Innovation Award for its bone regeneration device, Ossiofiber.

Regenerative medicine and cell therapy company InGeneron extended its Series D financing by up to $23 million, totaling $43 million, to be invested in the company.

Konica Minolta Healthcare is hosting an autologous biologics workshop in collaboration with EmCyte to support education for ultrasound-guided musculoskeletal inventions.

Bioventus has partnered with MTF Biologics to co-develop a placental tissue product for the treatment of painful musculoskeletal conditions, focusing initially on knee osteoarthritis.

Scottsdale, Ariz.-based R3 Stem Cell responded to an FDA letter that raised safety and legality concerns over R3's stem cell offerings.

A federal judge granted the FDA authority to regulate treatments from U.S. Stem Cell Clinic and U.S. Stem Inc., NBC News reports.

Niagara Falls (N.Y.) Memorial Medical Center and Andrew Cappuccino, MD, of Buffalo (N.Y.) Spine Surgery are opening a stem cell therapy center, reports WNY Papers.com.

A new study published in The Spine Journal examines outcomes from posterior lumbar fusions at a physician-owned hospital compared with a non-physician-owned hospital. 

Atlanta-based Emory Orthopedics & Spine Center's Ken Mautner, MD, is studying how three different stem cell therapies treat osteoarthritis, local news affiliate Fox 5 reports. 

A new study published in The Spine Journal examines long-term data on the risk for cancer associated with recombinant human bone morphogenetic protein use in spinal fusions.